Dipak Kumar Prajapati

Dipak Kumar Prajapati is a seasoned technocrat with over 21 years of industrial experience in the pharmaceutical sector, specializing in solid oral dosage formulations, soft gelatin, and liquid formulations. Currently serving as the Head of Operations at Mankind Pharma Ltd since December 2022, Dipak has previously held significant roles including Head of Production at MSN Laboratories, where responsibility included managing multiple manufacturing blocks with commercial volumes reaching up to 700 million per month. Additional experience encompasses positions at Aurobindo Pharma, Glenmark Generics, Lupin Ltd, Ranbaxy Ltd, and Cipla Ltd, with extensive expertise in areas such as commercial manufacturing, packing, planning, commissioning, and project layout finalization.